WK insider plans sale of 20,000 shares

The shareholder filing for the issuer with ticker WK indicates an intent to sell 20,000 shares of common stock through Merrill Lynch on or after August 5, 2026, on the NYSE.

Rhea-AI Filing Summary

The shareholder filing for the issuer with ticker WK indicates an intent to sell 20,000 shares of common stock through Merrill Lynch on or after August 5, 2026, on the NYSE. The shares have an aggregate market value of $1,220,622, compared with 52,549,753 shares outstanding.

Over the prior three months, the same shareholder reported additional sales of common stock, including 30,000 shares on July 16, 2026, 120,000 shares on July 1, 2026, and 20,204 shares on June 17, 2026, all for cash consideration.

Key Figures

Planned shares to be sold: 20,000 shares Aggregate market value of planned sale: $1,220,622 Shares outstanding: 52,549,753 shares +3 more

6 metrics

Planned shares to be sold 20,000 shares Common stock to be sold through Merrill Lynch on or after August 5, 2026

Aggregate market value of planned sale $1,220,622 Value of 20,000 shares of common stock to be sold

Shares outstanding 52,549,753 shares Total common shares outstanding for the issuer with ticker WK

Shares sold on July 16, 2026 30,000 shares Common stock sale for cash reported in the past three months

Shares sold on July 1, 2026 120,000 shares Common stock sale for cash reported in the past three months

Shares sold on June 17, 2026 20,204 shares Common stock sale for cash reported in the past three months

Key Terms

Securities To Be Sold, Securities Sold During The Past 3 Months, Common

3 terms

Securities To Be Sold financial

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months financial

"144: Securities Sold During The Past 3 Months"

Common financial

"Common | Merrill Lynch 7545 Ashworth Rd, Suite 100"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is being planned for WK in this filing?

The shareholder plans to sell 20,000 shares of WK common stock through Merrill Lynch on or after August 5, 2026. The planned sale is to occur on the NYSE and is valued at an aggregate $1,220,622 based on the filing.

How large is the planned WK share sale compared with shares outstanding?

The planned sale covers 20,000 shares versus 52,549,753 shares outstanding. This represents only a small fraction of the issuer’s common stock, providing context for the scale of the proposed disposition.

Who is the shareholder selling WK shares and through which broker?

The selling shareholder is Matthew Rizai, who intends to sell WK common stock through Merrill Lynch. The broker’s office is listed in West Des Moines, Iowa, as part of the transaction details.

What WK stock sales occurred in the past three months before this filing?

The shareholder reported selling 120,000 shares of WK on July 1, 2026, 30,000 shares on July 16, 2026, and 20,204 shares on June 17, 2026. All these transactions involved cash consideration for common stock.

On which exchange will the WK shares in this planned sale be traded?

The planned sale of 20,000 shares of WK common stock is to occur on the NYSE. The filing specifies NYSE as the trading market for this proposed disposition through Merrill Lynch.

What is the aggregate market value of WK shares planned for sale?

The filing reports an aggregate market value of $1,220,622 for the 20,000 shares of WK common stock to be sold. This figure provides the monetary scale of the proposed NYSE transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 05:58 PM Accepted by SEC EDGAR 08/05/2026 - 05:57 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001013631
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Workiva Inc.
SEC File Number
Address of Issuer	2900 University Blvd Ames IOWA 50010
Phone	888-275-3125
Name of Person for Whose Account the Securities are To Be Sold	Matthew Rizai
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 7545 Ashworth Rd, Suite 100 West Des Moines IA 50266	20000	1220622	52549753	08/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/12/2014	Cash	Issuer			2077058	12/12/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Matthew Rizai 2900 University Blvd Ames IA 50010	Common	07/16/2026	30000	1697901
Matthew Rizai 2900 University Blvd Ames IA 50010	Common	07/01/2026	120000	6047292
Matthew Rizai 2900 University Blvd Ames IA 50010	Common	06/17/2026	20204	986589.61

144: Remarks and Signature

Remarks
Date of Notice	08/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Matthew Rizai
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)